OTC Markets OTCPK - Delayed Quote USD
Plandaí Biotechnology, Inc. (PLPL)
0.0001
0.0000
(0.00%)
As of April 29 at 4:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Roger Baylis-Duffield | Co-Founder, Chairman and Chief Executive Officer | 180k | -- | 1943 |
| Mr. Callum Baylis-Duffield | President, Chief Operating Officer and Director | 120k | -- | 1985 |
| Mr. Ezra Jones | Vice President of Sales and Marketing | -- | -- | -- |
Plandaí Biotechnology, Inc.
- Sector:
- Financial Services
- Industry: Shell Companies
- Full Time Employees:
- 180
Description
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
Corporate Governance
Plandaí Biotechnology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available